PARK AVENUE SECURITIES LLC
Broker-DealerPosition in GILD — Gilead Sciences, Inc.
CIK 1071640
NEW YORK, NY
Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$9,000,587
-$2,206,851 QoQ
Shares Held
71,241
-11.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#448
of 2,266 holders
Holding Since
Jun 2020
25 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $165,157,657 across 14 Drug Manufacturers - General names. GILD ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,602 | $42,702,110 | |
| 2 | JNJ |
Johnson & Johnson
|
119,431 | $30,331,891 | |
| 3 | ABBV |
AbbVie Inc.
|
98,903 | $24,887,950 | |
| 4 | MRK |
Merck & Co., Inc.
|
106,866 | $13,732,281 | |
| 5 | AZN |
Astrazeneca PLC
|
53,856 | $10,212,174 | |
| 6 | AMGN |
Amgen Inc
|
27,835 | $10,079,610 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
71,241 | $9,000,587 | |
| 8 | NVS |
Novartis AG
|
43,915 | $6,882,358 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,000,587 | 71,241 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $11,207,438 | 80,415 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $9,939,362 | 80,979 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $8,748,576 | 78,816 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $8,285,093 | 74,728 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $4,541,722 | 40,533 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,655,914 | 28,753 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,834,000 | 21,875 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $1,921,628 | 28,008 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,596,053 | 35,441 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $5,217,449 | 64,405 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $4,221,070 | 56,326 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,922,092 | 50,890 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $3,999,651 | 48,206 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,390,369 | 51,140 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,395,854 | 38,837 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,892,374 | 30,616 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $946,562 | 15,922 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $995,483 | 13,710 | Shares | Sole | 2022-04-08 | |
| 2021-09-30 | $857,199 | 12,272 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $822,808 | 11,949 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $707,569 | 10,948 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $513,736 | 8,818 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $560,684 | 8,873 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $698,153 | 9,074 | Shares | Sole | 2020-07-30 | |
| No filing history on record for this holder in this stock. | ||||||